Overview

This trial is active, not recruiting.

Condition localized renal cell carcinoma
Treatment radical nephrectomy
Sponsor Seoul National University Hospital
Start date March 2009
Trial size 36 participants
Trial identifier NCT00945984, LESSRNx

Summary

Surgical resection is the only potential curative treatment available for renal cell carcinoma. The purpose of this study is to clarify the surgical and oncologic outcomes of laparoendoscopic single-site radical nephrectomy for localized Renal Cell Carcinoma.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case control
Time perspective retrospective
Arm
Patients who underwent LESS radical nephrectomy
radical nephrectomy
Surgical options to treat localized renal cell carcinoma
Patients who underwent conventional laparoscopic radical nephrectomy
radical nephrectomy
Surgical options to treat localized renal cell carcinoma

Primary Outcomes

Measure
Surgical outcomes such as operative time, estimated blood loss
time frame: 1 year

Eligibility Criteria

Male or female participants from 20 years up to 80 years old.

Inclusion Criteria: - Patients with localized renal cell carcinoma Exclusion Criteria: - Patients with lymph node or distant metastasis

Additional Information

Official title Comparison of Laparoendoscopic Single-site Radical Nephrectomy With Conventional Laparoscopic Radical Nephrectomy for Localized Renal Cell Carcinoma
Trial information was received from ClinicalTrials.gov and was last updated in July 2009.
Information provided to ClinicalTrials.gov by Seoul National University Hospital.